Publication | Closed Access

Salinomycin promotes T-cell proliferation by inhibiting the expression and enzymatic activity of immunosuppressive indoleamine-2,3-dioxygenase in human breast cancer cells

OncologyEnzymatic ActivityMedicineT-cell ProliferationBreast CancerAnti-cancer AgentTumor SuppressorImmunosuppressive Indoleamine-2,3-dioxygenasePharmacologyCell BiologyTumor MicroenvironmentCancer ResearchEndocrine-related Cancer